Pharmaron Beijing Co Ltd (PHBBF)
1.93
0.00 (0.00%)
USD |
OTCM |
Nov 14, 16:00
Pharmaron Beijing Enterprise Value
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 14, 2024 | 2.955B |
| November 13, 2024 | 2.955B |
| November 12, 2024 | 2.955B |
| November 11, 2024 | 2.955B |
| November 08, 2024 | 2.955B |
| November 07, 2024 | 2.955B |
| November 06, 2024 | 2.955B |
| November 05, 2024 | 2.955B |
| November 04, 2024 | 2.955B |
| November 01, 2024 | 2.955B |
| October 31, 2024 | 2.955B |
| October 30, 2024 | 2.955B |
| October 29, 2024 | 2.955B |
| October 28, 2024 | 2.955B |
| October 25, 2024 | 2.955B |
| October 24, 2024 | 2.955B |
| October 23, 2024 | 2.955B |
| October 22, 2024 | 2.955B |
| October 21, 2024 | 2.955B |
| October 18, 2024 | 2.955B |
| October 17, 2024 | 2.955B |
| October 16, 2024 | 2.955B |
| October 15, 2024 | 2.955B |
| October 14, 2024 | 2.955B |
| October 11, 2024 | 2.955B |
| Date | Value |
|---|---|
| October 10, 2024 | 2.955B |
| October 09, 2024 | 2.955B |
| October 08, 2024 | 2.955B |
| October 07, 2024 | 2.955B |
| October 04, 2024 | 2.955B |
| October 03, 2024 | 2.955B |
| October 02, 2024 | 2.955B |
| October 01, 2024 | 2.955B |
| September 30, 2024 | 2.955B |
| September 27, 2024 | 2.955B |
| September 26, 2024 | 2.955B |
| September 25, 2024 | 2.955B |
| September 24, 2024 | 2.955B |
| September 23, 2024 | 2.955B |
| September 20, 2024 | 2.955B |
| September 19, 2024 | 2.955B |
| September 18, 2024 | 2.955B |
| September 17, 2024 | 2.955B |
| September 16, 2024 | 2.955B |
| September 13, 2024 | 2.955B |
| September 12, 2024 | 2.955B |
| September 11, 2024 | 2.955B |
| September 10, 2024 | 2.955B |
| September 09, 2024 | 2.955B |
| September 06, 2024 | 2.955B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
2.955B
Minimum
May 14 2024
3.369B
Maximum
Sep 27 2023
3.005B
Average
2.955B
Median
May 14 2024
Enterprise Value Benchmarks
| Sino Biopharmaceutical Ltd | 8.600B |
| HUTCHMED (China) Ltd | 2.171B |
| Regencell Bioscience Holdings Ltd | 71.42M |
| Prenetics Global Ltd | 9.425M |
| Uni-Bio Science Group Ltd | 13.51M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 50.88M |
| Revenue (Quarterly) | 397.98M |
| Total Expenses (Quarterly) | 335.19M |
| EPS Diluted (Quarterly) | 0.0431 |